With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. https://ichef.bbci.co.uk/news/1024/branded_news/e55b/live/00c290a0-2238-11f1-a79a-77e93010d956.jpg 2026-03-17…
Read More
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies…
Read More
Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey |…
Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk,…
Read More
Obesity pills from Eli Lilly, Novo Nordisk near US launch
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medications: pills. Both…
Read MoreYOU MAY HAVE MISSED
Social Media Auto Publish Powered By : XYZScripts.com